Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42000653EBVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30013028HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30078106HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055932HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055933HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055934HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055935HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055936HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055937HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055938HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TCGA Plot Options
Drug Information
GenePPARA
DrugBank IDDB11133
Drug NameOmega-3 fatty acids
Target IDBE0000071
UniProt IDQ07869
Regulation Typeactivator
PubMed IDs19585164; 24986106
CitationsRudkowska I, Garenc C, Couture P, Vohl MC: Omega-3 fatty acids regulate gene expression levels differently in subjects carrying the PPARalpha L162V polymorphism. Genes Nutr. 2009 Sep;4(3):199-205. doi: 10.1007/s12263-009-0129-2. Epub 2009 Jul 8.@@Liu M, Montgomery MK, Fiveash CE, Osborne B, Cooney GJ, Bell-Anderson K, Turner N: PPARalpha-independent actions of omega-3 PUFAs contribute to their beneficial effects on adiposity and glucose homeostasis. Sci Rep. 2014 Jul 2;4:5538. doi: 10.1038/srep05538.
GroupsApproved; Nutraceutical
Direct Classification
SMILES
Pathways
PharmGKB
ChEMBL